Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Srivichaivejvivat PCLBKK:VIH-R 80 Net Cash per Share is ฿1.42 as of Mar. 2026, which is 100% below its 10-year median of 11.04. GuruFocus rates BKK:VIH-R with a GF Score™ of 80/100 and a GF Value™ of ฿8.83. The stock has 4 warning signs investors should review. Among 151 Healthcare Providers & Services companies, Srivichaivejvivat PCL ranks better than 58.94% on this metric.
The historical rank and industry rank for Srivichaivejvivat PCL's Net Cash per Share or its related term are showing as below:
BKK:VIH-R'
s Price-to-Net-Cash Range Over the Past 10 Years
Min: 6.01 Med: 11.04 Max: 915
Current: 6.01
During the past 13 years, the highest Price-to-Net-Cash Ratio of Srivichaivejvivat PCL was 915.00. The lowest was 6.01. And the median was 11.04.
BKK:VIH-R's Price-to-Net-Cash is ranked better than 58.94% of 151
companies
in the Healthcare Providers & Services industry
Industry Median: 8
vs BKK:VIH-R: 6.01
Srivichaivejvivat PCL (BKK:VIH-R) Net Cash per Share Explanation
Ben Graham invested in situations where the company's stock price was lower than its net-cash. He assigned some value to the company's other current asset. The value is called Net Current Asset Value (NCAV). One research study, covering the years 1970 through 1983 showed that portfolios picked at the beginning of each year, and held for one year, returned 29.4 percent, on average, over the 13-year period, compared to 11.5 percent for the S&P 500 Index. Other studies of Graham's strategy produced similar results.
You can find companies that are traded below their Net Current Asset Value (NCAV) with our Net-Net screener.
Srivichaivejvivat PCL Net Cash per Share Related Terms
Srivichaivejvivat PCL Net Cash per Share Historical Data
* Premium members only.
The historical data trend for Srivichaivejvivat PCL's Net Cash per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BKK:VIH-R vs HCA, THC, DVA: Net Cash per Share Comparison
For the Medical Care Facilities subindustry, Srivichaivejvivat PCL's Price-to-Net-Cash, along with its competitors' market caps and Price-to-Net-Cash data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Srivichaivejvivat PCL Price-to-Net-Cash vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Srivichaivejvivat PCL's Price-to-Net-Cash distribution charts can be found below:
* The bar in red indicates where Srivichaivejvivat PCL's Price-to-Net-Cash falls into.
Srivichaivejvivat PCL Net Cash per Share Calculation
In the calculation of a company's Net Cash per Share, assets other than cash and short term investments are considered to be worth nothing. But the company has to pay its debt and other liabilities in full. This is an extremely conservative way of valuation. Most companies have negative Net Cash per Share. But sometimes a company's price may be lower than its net-cash.
Srivichaivejvivat PCL's Net Cash per Share for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Srivichaivejvivat PCL (BKK:VIH-R) has a Net Cash per Share of ฿1.42 as of Mar. 2026. Net cash per share equals the per-share value of cash and equivalents less total liabilities and minority interest. View historical data on Srivichaivejvivat PCL and its competitors. This is 87% below median its historical median of 11.04. Over the past decade, Srivichaivejvivat PCL's Net Cash per Share has ranged from 6.01 to 915.00. According to the industry distribution chart, Srivichaivejvivat PCL ranks #62 out of 151 companies in the Healthcare Providers & Services industry, placing it in the top 41.1%.
Is Srivichaivejvivat PCL's Net Cash per Share too high?
Srivichaivejvivat PCL's current Net Cash per Share of ฿1.42 is 87% below median its 10-year median of 11.04. Over the past 10 years, this metric has ranged from a low of 6.01 to a high of 915.00. Based on the distribution chart, Srivichaivejvivat PCL ranks #62 out of 151 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Srivichaivejvivat PCL has a GF Score™ of 80/100, reflecting its overall financial health beyond just this single metric.
How does Srivichaivejvivat PCL's Net Cash per Share compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Srivichaivejvivat PCL ranks #62 out of 151 companies for Net Cash per Share. This puts Srivichaivejvivat PCL in the upper half of its industry. The industry median Net Cash per Share is 8.00. Historically, Srivichaivejvivat PCL's own Net Cash per Share has ranged from 6.01 to 915.00 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Cash per Share for a Healthcare Providers & Services company?
The median Net Cash per Share among Healthcare Providers & Services companies is 8.00, based on 151 companies in the industry. Companies in the top quartile (top 25%) have a Net Cash per Share significantly above this median, while those in the bottom quartile fall well below. However, Net Cash per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Cash per Share mean?
A high Net Cash per Share can signal that a stock is expensive relative to its fundamentals. Net cash per share equals the per-share value of cash and equivalents less total liabilities and minority interest. View historical data on Srivichaivejvivat PCL and its competitors. For the Healthcare Providers & Services industry, the median Net Cash per Share is 8.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Srivichaivejvivat PCL's current Net Cash per Share is ฿1.42, which is 87% below median its own 10-year median of 11.04. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Srivichaivejvivat PCL stock overvalued right now?
Srivichaivejvivat PCL (BKK:VIH-R) has a current Net Cash per Share of ฿1.42. The stock's GF Value™ is ฿8.83, compared to a current price of ฿8.95 — trading 1.4% above its estimated fair value. The current Net Cash per Share is ฿1.42, which is 87% below median its 10-year median of 11.04. Srivichaivejvivat PCL's overall GF Score™ is 80/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Cash per Share calculated?
Net Cash per Share is calculated from a company's financial statements. For Srivichaivejvivat PCL (BKK:VIH-R), the current Net Cash per Share is ฿1.42 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Srivichaivejvivat PCL (BKK:VIH-R) Overvalued in 2026?
Based on GuruFocus' analysis, Srivichaivejvivat PCL stock appears to be overvalued.
The current stock price of ฿8.95 is trading 1.4% above its estimated GF Value™ of ฿8.83.
Key valuation signals for BKK:VIH-R:
Net Cash per Share: ฿1.42 (87% below median its 10-year median of 11.04)
GF Value™: ฿8.83 vs. price of ฿8.95 (1.4% above fair value)
No single metric tells the full story. See the BKK:VIH-R stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Srivichaivejvivat PCL is engaged in hospital business. The company provides 24-hour medical treatment by specialized doctors, with services in the outpatient department (OPD) by specialized doctors until midnight. Specialized clinics are available, such as comprehensive laparoscopic surgery, orthopedic surgery, urology, vascular surgery, cardiology, nephrology and hemodialysis center, endocrinology, neurology, gastroenterology, pediatric clinic, obstetrics and gynecology clinic, emergency accident center, dental center, health check-up center, Thai Filos Anti-Aging Center. It operates in single segment of hospital business in Thailand only.
80GF Score
Get the complete analysis for BKK:VIH-R
Net Cash per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BKK:VIH-R has been successfully added to your 
